Efficacy and Safety of Novel Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in the Management of Diabetic Kidney Disease: A Meta-analysis

BACKGROUND: Data are scant on use of finerenone in diabetic kidney disease (DKD). We undertook this meta-analysis to address this knowledge gap. METHODS: Electronic databases were searched for randomized controlled trials (RCTs) involving diabetes patients receiving finerenone compared to controls....

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, Surana, Vineet, Bhattacharya, Saptarshi, Aggarwal, Sameer, Sharma, Meha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555385/
https://www.ncbi.nlm.nih.gov/pubmed/36248038
http://dx.doi.org/10.4103/ijem.ijem_376_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555385/
https://www.ncbi.nlm.nih.gov/pubmed/36248038
http://dx.doi.org/10.4103/ijem.ijem_376_21

Ejemplares similares